KOR

e-Article

P0901 : The pan-genotypic NS3/4A protease inhibitor GS-9857 demonstrates potent antiviral activity in patients infected with HCV genotype 1, 2, 3 or 4 in a 3-day monotherapy study
Document Type
Abstract
Source
In Journal of Hepatology April 2015 62 Supplement 2:S682-S682
Subject
Language
ISSN
0168-8278